Profile
Johan Van Hoof currently works at P.J.A.
Beheer, as Managing Director & Director from 2017 and Ziphius Vaccines NV, as Non-Executive Director.
Johan Van Hoof active positions
| Companies | Position | Start |
|---|---|---|
P.J.A. Beheer
 P.J.A. Beheer Financial ConglomeratesFinance P.J.A. Beheer is an investment holding Belgian company. The private company was founded in 2003. Johan Van Hoof has been the CEO of the company since 2017. | Chief Executive Officer | 30/09/2017 |
Ziphius Vaccines NV
 Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
P.J.A. Beheer
P.J.A. Beheer Financial ConglomeratesFinance P.J.A. Beheer is an investment holding Belgian company. The private company was founded in 2003. Johan Van Hoof has been the CEO of the company since 2017. | Finance |
Ziphius Vaccines NV
Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Johan Van Hoof
